Considering that a comparable dose of TNF is inactive in the WEHI-fibrosarcoma model [38], these results suggest that the G4 moiety of the conjugate, like CNGRC, can indeed enable the targeted delivery of TNF to the tumor vasculature. This evidence concerns the gene TNF and neoplasm.